Shanghai Henlius Biotech, Inc. (HKG:2696)

Shanghai Henlius Biotech Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	38,969	31,006	12,881	7,555	6,957	11,984
Market Cap Growth	156.07%	140.72%	70.50%	8.59%	-41.95%	-53.03%
Enterprise Value	42,033	33,962	16,522	11,112	10,233	13,635
Last Close Price	71.70	57.05	23.70	13.90	12.80	22.05
PE Ratio	42.67	33.69	14.75	12.56	-	-
Forward PE	25.96	27.52	15.91	12.55	-	-
PS Ratio	5.25	4.18	2.11	1.27	1.91	5.80
PB Ratio	8.84	7.04	4.02	3.13	3.76	4.25
P/TBV Ratio	-	-	-	-	-	25.87
P/FCF Ratio	-	-	11.23	11.94	15.51	-
P/OCF Ratio	-	-	9.75	6.54	6.27	108.01
EV/Sales Ratio	5.67	4.58	2.71	1.87	2.82	6.60
EV/EBITDA Ratio	33.95	27.44	13.36	10.82	-	-
EV/EBIT Ratio	46.23	37.35	17.92	15.45	-	-
EV/FCF Ratio	-	-	14.40	17.57	22.82	-
Debt / Equity Ratio	0.91	0.91	1.21	1.87	2.25	1.14
Debt / EBITDA Ratio	3.23	3.23	2.96	4.07	-	-
Debt / FCF Ratio	-	-	3.39	7.13	9.27	-
Net Debt / Equity Ratio	0.70	0.70	0.94	1.41	1.81	0.82
Net Debt / EBITDA Ratio	2.48	2.48	2.44	3.31	-7.06	-3.63
Net Debt / FCF Ratio	-	-	2.63	5.37	7.48	-5.08
Asset Turnover	0.58	0.58	0.56	0.57	0.40	0.25
Inventory Turnover	2.51	2.51	2.07	1.95	1.44	1.44
Quick Ratio	0.54	0.54	0.34	0.34	0.27	0.35
Current Ratio	0.71	0.71	0.50	0.53	0.44	0.56
Return on Equity (ROE)	23.72%	23.72%	31.52%	28.52%	-35.35%	-35.81%
Return on Assets (ROA)	4.45%	4.45%	5.28%	4.33%	-4.88%	-6.11%
Return on Invested Capital (ROIC)	12.17%	13.01%	15.11%	12.67%	-14.32%	-16.48%
Return on Capital Employed (ROCE)	11.00%	11.00%	15.60%	13.50%	-16.00%	-15.80%
Earnings Yield	2.36%	2.97%	6.78%	7.96%	-11.30%	-10.08%
FCF Yield	-	-	8.91%	8.37%	6.45%	-3.79%
Buyback Yield / Dilution	-0.45%	-0.45%	-0.02%	-0.25%	-0.59%	-1.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.